Google recently presented a new AI system called AlphaProteo designed for health and biological research. According to Google, this new technology has the “potential for advancing drug design, disease understanding, and more”.
“Today, we introduce AlphaProteo, our first AI system for designing novel, high-strength protein binders to serve as building blocks for biological and health research”, the company stated in a blog post.
AlphaProteo is claimed to be the first of its kind; an AI system that can generate novel proteins that bind with target molecules. Such binding proteins can help researchers in various fields including drug development, cancer treatment, and cell and tissue imaging. Google also states this technology can aid in understanding and properly diagnosing human diseases.
See Related: Google Announces DeepMind; Accelerating Its Attempt At Leading The AI Race
The reveal of AlphaProteo is in keeping with Google’s endeavor to create AI tools to further health-related research. Earlier this year, the company launched AlphaFold 3, an AI model that can predict protein structures. They have also released AlphaMissense which catalogs millions of genetic mutations.
AlphaProteo is trained using data from the Protein Data Bank. It also incorporates “more than 100 million predicted structures” from Google’s other AI systems, including AlphaFold.
AlphaProteo was developed by two research teams under Google: the Protein Design team and the Wet Lab team. Currently, the model is in development.
